TITLE

Segregation analysis of apolipoprotein A1 levels in families of adolescents: A community-based study in Taiwan

AUTHOR(S)
Chien, Kuo-Liong; Chen, Wei J; Hsu, Hsiu-Ching; Su, Ta-Chen; Chen, Ming-Fong; Lee, Yuan-Teh
PUB. DATE
January 2006
SOURCE
BMC Genetics;2006, Vol. 7, p4
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Apolipoprotein (Apo) A1 is a protective factor for cardiovascular events. This study aimed to perform complex segregation analyses of Apo A1 levels in families of adolescents systematically ascertained from the junior high school students in a rural community. Both siblings and parents of the adolescent probands were recruited for the study. Apo A1 concentrations were measured by turbidimetric immunoassay methods. After adjustment for gender, age, body mass index, smoking and drinking status, residual values of Apo A1 were subjected to subsequent analyses. Results: Significant mother-father and parent-offspring correlations were found. Commingling analyses indicated that a four-component distribution model was needed to account for the Apo A1 variation. Segregation analysis using regressive models revealed that the best-fit model of Apo A1 was a model of environmental effect plus familial correlation (heritability = 23.9%), in which a significant mother-father correlation existed. Models containing major gene effect could be rejected. Conclusion: These results suggest that variations of Apo A1 levels in the normal range, especially during adolescence, are likely to be influenced by multiple factors without significant contribution from major genes.
ACCESSION #
29324037

 

Related Articles

  • Discovery and consequences of apolipoprotein-ℇ3Groningen: a G-insertion in codon 95/96 that is predicted to cause a premature stop codon. Dijck-Brouwer, D A Janneke; van Doormaal, Jasper J; Kema, Ido P; Brugman, Astrid M; Kingma, Anneke W; Muskiet, Frits A J // Annals of Clinical Biochemistry;Jul2005, Vol. 42 Issue 4, p264 

    Background: We found an unexplained, persistent discrepancy between the outcomes of two apolipoprotein-E (apo-E) genotyping methods for a patient with features of familial dysbetalipoproteinaemia (FD). Polymerase chain reaction – restriction fragment length polymorphism resulted in the...

  • Normal metabolism of apolipoprotein B100-containing lipoproteins despite qualitative abnormalities in type 1 diabetic men. Duvillard, L.; Florentin, E.; Lalanne-Mistrich, M. L.; Petit, J. M.; Baillot-Rudoni, S.; Brun-Pacaud, A.; Brun, J. M.; Gambert, P.; Vergès, B. // Diabetologia;Jul2005, Vol. 48 Issue 7, p1366 

    Aims/hypothesis: Type 1 diabetic subjects are at increased risk of cardiovascular disease and exhibit multiple qualitative abnormalities of apolipoprotein (apo) B100-containing lipoproteins. This stable isotope kinetic experiment was designed to study whether these abnormalities are associated...

  • Effect of serum subfractions from peritoneal dialysis patients on Hep-G2 cell apolipoprotein A-I and B metabolism. Shah, Gaurang M.; Lin, Zuo-Lun; Kamanna, Vaijinath S.; Pai, Rama; Bassa, Babu; Jin, Fu-You; Roh, Daeyoung Dave; Kashyap, Moti L.; Kirschenbaum, Michael A. // Kidney International;Dec1996, Vol. 50 Issue 6, p2079 

    We previously showed that uremic serum subfractions isolated from hemodialysis (HD) patients inhibited the production of apolipoprotein (apo) A-I by human hepatoblastoma cells, Hep-G2. Because of the reported differences in atherogenic cardiovascular morality between HD and peritoneal dialysis...

  • In vitro transcriptional induction of the human apolipoprotein A-II gene by glucose. Sauvaget, Dominique; Chauffeton, Valérie; Dugué-Pujol, Sonia; Kalopissis, Athina-Despina; Guillet-Deniau, Isabelle; Foufelle, Fabienne; Chambaz, Jean; Leturque, Armelle; Cardot, Philippe; Ribeiro, Agnès; Chauffeton, Valérie; Dugué-Pujol, Sonia; Ribeiro, Agnès // Diabetes;Mar2004, Vol. 53 Issue 3, p672 

    Type 2 diabetic patients present high triglyceride and low HDL levels, significant determinants for the risk of atherosclerosis. Transgenic mice overproducing human apolipoprotein (apo)A-II, one of the two major apos of HDLs, display the same lipid disorders. Here, we investigated the possible...

  • Hemodialysis reduces plasma apolipoprotein C-I concentration making VLDL a better substrate for lipoprotein lipase. Dautin, G.; Soltani, Z.; Ducloux, D.; Gautier, T.; de Barros, J. P. Pais; Gambert, P.; Lagrost, L.; Masson, D. // Kidney International;Oct2007, Vol. 72 Issue 7, p871 

    Apolipoprotein Cs (apoC-1, apoC-II, and apoC-III) are lipoprotein components that have regulatory effects on enzymes involved in lipoprotein metabolism. Owing to their low molecular weights, apoCs can adsorb onto and/or pass through dialysis membranes. Our study determines the consequence of...

  • Serum Apolipoproteins C-I and C-III Are Reduced in Stomach Cancer Patients: Results from MALDI-Based Peptidome and Immuno-Based Clinical Assays. Cohen, Meital; Yossef, Rami; Erez, Tamir; Kugel, Aleksandra; Welt, Michael; Karpasas, Mark M.; Bones, Jonathan; Rudd, Pauline M.; Taieb, Julien; Boissin, Herve; Harats, Dror; Noy, Karin; Tekoah, Yoram; Lichtenstein, Rachel G.; Rubin, Eitan; Porgador, Angel // PLoS ONE;2011, Vol. 6 Issue 1, p1 

    Finding new peptide biomarkers for stomach cancer in human sera that can be implemented into a clinically practicable prediction method for monitoring of stomach cancer. We studied the serum peptidome from two different biorepositories. We first employed a C8-reverse phase liquid chromatography...

  • Comprehensive Evaluation of the Association of APOE Genetic Variation with Plasma Lipoprotein Traits in U.S. Whites and African Blacks. Radwan, Zaheda H.; Wang, Xingbin; Waqar, Fahad; Pirim, Dilek; Niemsiri, Vipavee; Hokanson, John E.; Hamman, Richard F.; Bunker, Clareann H.; Barmada, M. Michael; Demirci, F. Yesim; Kamboh, M. Ilyas // PLoS ONE;Dec2014, Vol. 9 Issue 12, p1 

    Although common APOE genetic variation has a major influence on plasma LDL-cholesterol, its role in affecting HDL-cholesterol and triglycerides is not well established. Recent genome-wide association studies suggest that APOE also affects plasma variation in HDL-cholesterol and triglycerides. It...

  • Interactions of the apolipoprotein C-III 3238C>G polymorphism and alcohol consumption on serum triglyceride levels. Yin Ruixing; Li Yiyang; Li Meng; Li Kela; Long Xingjiang; Zhang Lin; Liu Wanying; Wu Jinzhen; Yang Dezhai; Lin Weixiong // Lipids in Health & Disease;2010, Vol. 9, p86 

    Background: Both apolipoprotein (Apo) C-III gene polymorphism and alcohol consumption have been associated with increased serum triglyceride (TG) levels, but their interactions on serum TG levels are not well known. The present study was undertaken to detect the interactions of the ApoC-III...

  • Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels.  // Lipids in Health & Disease;2011, Vol. 10 Issue 1, p140 

    The article cites a research study that analyzes the relationship between the ApoA1/C3/A5 gene polymorphisms and their haplotypes with serum lipid levels. The relationship of single nucleotide polymorphisms (SNPs) in the apolipoprotein (Apo) A1/C3/A4/A5 gene cluster and serum lipid profiles is...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics